earnings
OV
NASDAQ · OVID
Ovid Therapeutics Inc.
Healthcare · Biotechnology
$2.40
Down-$0.14 (-5.51%)
Updated Nov 17, 2026, 2:46 AM
SID Score
5.0/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 117.35M
- P/E ratio
- -0.06
- Dividend yield
- 0.00%
- 52-week range
- $1.18 – $3.11
- Volume
- 2.8M
- Avg. volume
- 2.89M
Price performance · OVID
OVID price history
1M range · 21 trading sessions · Daily adjusted prices
Prices through Nov 16, 2026
OVID closed at $2.40 after 21 trading sessions, up 10.60% for the selected period.
- Last close
- $2.40
- Period change
- +10.60%
- Period low
- $2.16
- Period high
- $2.85
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 16, 2026 | $2.52 | $2.655 | $2.37 | $2.40 | 2.8M |
| Nov 13, 2026 | $2.50 | $2.555 | $2.33 | $2.54 | 2.9M |
| Nov 12, 2026 | $2.77 | $2.77 | $2.51 | $2.55 | 2.92M |
| Nov 11, 2026 | $2.80 | $2.86 | $2.66 | $2.78 | 1.82M |
| Nov 10, 2026 | $2.76 | $2.87 | $2.64 | $2.80 | 2.31M |
| Nov 9, 2026 | $2.89 | $3.09 | $2.83 | $2.85 | 6.22M |
| Nov 6, 2026 | $2.56 | $2.945 | $2.5585 | $2.85 | 3.9M |
| Nov 5, 2026 | $2.74 | $2.7499 | $2.485 | $2.58 | 2.02M |
| Nov 4, 2026 | $2.50 | $2.79 | $2.375 | $2.74 | 3.61M |
| Nov 3, 2026 | $2.39 | $2.495 | $2.38 | $2.40 | 1.38M |
| Nov 2, 2026 | $2.55 | $2.60 | $2.37 | $2.39 | 2.34M |
| Oct 30, 2026 | $2.51 | $2.70 | $2.44 | $2.54 | 3.15M |
| Oct 29, 2026 | $2.45 | $2.58 | $2.405 | $2.56 | 2.04M |
| Oct 28, 2026 | $2.26 | $2.495 | $2.205 | $2.45 | 2.06M |
| Oct 27, 2026 | $2.18 | $2.28 | $2.10 | $2.26 | 1.69M |
| Oct 26, 2026 | $2.19 | $2.22 | $2.1213 | $2.155 | 844.07K |
| Oct 23, 2026 | $2.31 | $2.32 | $2.12 | $2.16 | 2.02M |
| Oct 22, 2026 | $2.45 | $2.50 | $2.34 | $2.37 | 1.18M |
| Oct 21, 2026 | $2.37 | $2.65 | $2.345 | $2.47 | 5.01M |
| Oct 20, 2026 | $2.19 | $2.46 | $2.175 | $2.36 | 3.67M |
| Oct 19, 2026 | $2.18 | $2.225 | $2.14 | $2.17 | 1.64M |
Latest OVID news
The latest Smart Investors Daily articles mentioning OVID.
Stock researchCompany · Earnings
Company
Market Activity
Research & News
Loading stock research…

